KLRK1 and neoplasm: Recognition of abnormal self on tumor cells triggers a number of non-MHC class I-restricted activating receptors, such as NK group 2D (NKG2D), DNAX accessory molecule-1 (CD226), and the natural cytotoxicity receptors (1).